Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis.
Vaccinia virus (VACV), the prototype poxvirus, encodes numerous proteins that modulate the host response to infection. Two such proteins, B14 and A52, act inside infected cells to inhibit activation of NF-kappaB, thereby blocking the production of pro-inflammatory cytokines. We have solved the cryst...
Hlavní autoři: | Graham, S, Bahar, M, Cooray, S, Chen, R, Whalen, D, Abrescia, N, Alderton, D, Owens, R, Stuart, D, Smith, G, Grimes, J |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Public Library of Science
2008
|
Podobné jednotky
-
Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis.
Autor: Stephen C Graham, a další
Vydáno: (2008-08-01) -
Mapping the IkappaB kinase beta (IKKbeta)-binding interface of the B14 protein, a vaccinia virus inhibitor of IKKbeta-mediated activation of nuclear factor kappaB.
Autor: Benfield, C, a další
Vydáno: (2011) -
Nuclear Factor-kappaB in Autoimmunity: Man and Mouse
Autor: Bahar Miraghazadeh, a další
Vydáno: (2018-04-01) -
NF-kappaB-inducing kinase is dispensable for activation of NF-kappaB in inflammatory settings but essential for lymphotoxin beta receptor activation of NF-kappaB in primary human fibroblasts.
Autor: Smith, C, a další
Vydáno: (2001) -
Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant.
Autor: Andreakos, E, a další
Vydáno: (2006)